Literature DB >> 4358435

Inhibition of adrenergic vasoconstriction by quinidine.

P G Schmid, L D Nelson, A L Mark, D D Heistad, F M Abboud.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4358435

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  6 in total

1.  Antagonism of adenosine 5'-triphosphate-induced relaxation by 2-2'-pyridylisatogen in the taenia of guinea-pig caecum.

Authors:  M Spedding; A J Sweetman; D F Weetman
Journal:  Br J Pharmacol       Date:  1975-04       Impact factor: 8.739

2.  Inhibition of adrenaline-induced platelet aggregation by the alpha-adrenoceptor blocking drug benextramine.

Authors:  B Belleau; B G Benfey; C Melchiorre; M Montambault
Journal:  Br J Pharmacol       Date:  1982-06       Impact factor: 8.739

3.  The effect of quinidine and its metabolites on the electrocardiogram and systolic time intervals: concentration--effect relationships.

Authors:  N H Holford; P E Coates; T W Guentert; S Riegelman; L B Sheiner
Journal:  Br J Clin Pharmacol       Date:  1981-02       Impact factor: 4.335

4.  Stereoselective effects of the enantiomers, quinidine and quinine, on depolarization- and agonist-mediated responses in rat isolated aorta.

Authors:  B F del Pozo; F Pérez-Vizcaíno; E Villamor; F Zaragozá; J Tamargo
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

Review 5.  Poisoning due to class IA antiarrhythmic drugs. Quinidine, procainamide and disopyramide.

Authors:  S Y Kim; N L Benowitz
Journal:  Drug Saf       Date:  1990 Nov-Dec       Impact factor: 5.606

6.  Voltage- and time-dependent inhibitory effects on rat aortic and porcine coronary artery contraction induced by propafenone and quinidine.

Authors:  F Pérez-Vizcaíno; B Fernández del Pozo; F Zaragozá; J Tamargo
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.